Business, energy, technology, markets and global industry news from Business News Today

Antiviral drugs

PharmaDeviceNews Antiviral drugs
Representative image of pharmaceutical manufacturing and respiratory medicine research. Lupin Limited’s China approval for oseltamivir phosphate oral suspension highlights the continuing role of paediatric-friendly antiviral formulations in influenza treatment access.
Pharma & Biotech

Can Lupin use oseltamivir approval to deepen its China respiratory medicine strategy?

Lupin’s China approval adds a paediatric-friendly flu antiviral to its portfolio. See why formulation and access still matter in generics.

Read More
Pharma & Biotech

Lupin just cracked China with a flu drug. Why investors may want to look closer

Lupin’s China debut starts with flu medicine. The bigger story is whether one approval can open a larger paediatric pharma pathway.

Read More
Representative image: Traws Pharma’s push into potential hantavirus treatment candidates highlights the growing need for antiviral drug development against rare but severe rodent-borne viral infections.
Pharma & Biotech

Can Traws Pharma turn hantavirus urgency into a credible antiviral program?

Hantavirus has no specific antiviral option. Traws Pharma’s next test is turning outbreak urgency into credible clinical candidates.

Read More